Key facts
- This page summarizes Amit Kumar's Form 4 filing for Anixa Biosciences Inc (ANIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2026, 08:45.
Amit Kumar - 31 Jul 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ANIX
- Reported as of
- 31 Jul 2026
- Net transaction value
- +$17,350
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2026, 08:45:18 UTC
- Prior SEC filing
- 28 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amit Kumar
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Amit Kumar filed Form 4 for Anixa Biosciences Inc (ANIX) on 03 Aug 2026.
Change
- Previous filing in this sequence was filed on 28 Jul 2026.
- Current net transaction value: +$17,350.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001191905
Primary reporting owner
KUMAR AMIT
- Relationship
- Chief Executive Officer, Director
- Address
- C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE,
- Signature
- /s/ Amit Kumar
- Signature date
- 03 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANIX
transaction
Common Stock
Purchase
- Transaction value
- $17,350
- Shares
- +5,000
- Change %
- +0.77%
- Price
- $3.47
- Shares after
- 657,000
- Date
- 31 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.